Associations Between Dental Anomalies and Ocular, Cutaneous and Skin Appendages Features

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-70
SponsorUniversity of Pavia

About this trial

Considering recent literature, it is possible to hypothesise a link between dental anomalies and ocular and/or cutaneous findings, given the existence of shared genetic and developmental mechanisms between these two anatomical areas. Both the eye and teeth develop from ectodermal and mesenchymal tissues, involving common molecular signalling pathways such as Wnt, BMP and PAX. Genetic variants affecting these pathways can therefore determine combined phenotypes, such as congenital cataracts associated with dental agenesis or enamel malformations. Some rare genetic syndromes, such as Nance-Horan syndrome and oculofacio-cardio-dental (OFCD) syndrome, support the hypothesis of a systemic correlation between odontogenesis and ocular development. In a previous study on congenital cataracts, nearly 10% of probands with variants in the BCOR, CWC27, IFIH1, NHS, and PAX6 genes had various dental abnormalities. Therefore, exploring the possible connection between eye and dental diseases may not only facilitate early and multidisciplinary diagnosis, but also open up new perspectives in genetic research and the development of personalised therapeutic approaches, for which whole genome sequencing (WGS) appears to be the first choice for investigating non-syndromic forms. Therefore, the current clinical study aims to identify variants in genes common to eye diseases and dental anomalies (agenesis, supernumerary teeth, Hutchinson's teeth, mulberry molars) in orthodontic patients over the age of 12 with dental anomalies who are about to begin orthodontic treatment or who are attending routine check-ups at the Orthodontics and Paediatric Dentistry Unit, Department of Clinical, Surgical, Diagnostic and Paediatrics Sciences at the University of Pavia who have a family history of ocular and cutaneous manifestations or presenting at the same time dental, ocular and/or cutaneous anomalies. Patients who are eligible will be invited to participate in the study. After signing the informed consent form, the Case Report Form will be completed to collect the data of interest for the study; previous medical reports will be asked to patients or parents/legal guardians in case of minors to ascertain ocular and cutaneous pathologies; a buccal swab will be taken to collect a DNA sample that will be analysed with Next Generation Sequencing. In addition, cephalometric evaluations will be performed if lateral teleradiographs will be available, if already performed in accordance with Good Clinical Practice for the purposes of orthodontic assessment of patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Supernumerary teeth

oligodontia

screw driver sharped incisors

Hutchinson's teeth

Disqualifiers

Previous orthodontic, restorative, endodontic, prosthetic and surgical treatment that could alter tooth morphology and position

Trial design

Design model

Single group

Treatments tested in this trial

  • Whole Genome Sequencing

    Genetic

    Genetic testing will be performed to find variants in genes involving congenital cataract and/or ocular diseases (keratitis, keratoconus, corneal dystrophies, ectopia lentis, glaucoma, retinitis pigmentosa, coloboma and aniridia) and dental anomalies (tooth agenesis, supernumerary teeth, Hutchinson teeth, mulberry molars). Cutaneous appendage anomalies will be also evaluated in clinical history for ascertaining ectodermal diplasia.

  • Cephalometric tracing

    Other intervention

    Cephalometric tracing will be performed on lateral cephalometric radiographs if present and not taken on purpose for the study

Treatment groups

5 Participants
are divided into 1 treatment group
Group A: Orthodontic patientsExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Presence of variants in common genes for dental anomalies, ocular diseases and cutaneous/skin appendages features

Whole Genome Sequencing will be used to find pathogenetic variants

Time frame
Baseline

Secondary outcomes

1

SNA angle

Angle between the sella, nasion and A point measured on lateral cephalometric radiograph

Time frame
Baseline
2

SNB angle

Angle between the sella, nasion and B point measured on lateral cephalometric radiograph

Time frame
Baseline
3

ANB angle

Angle between point A, the nasion and point B measured on lateral cephalometric radiograph

Time frame
Baseline
4

SN plane

Plane between the sella point S and nasion point N measured on lateral cephalometric radiograph

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: